S. R. Stornelli, D. Lacedonia, G. Scioscia, F. Simone, G. Lepore, R. Sabato, G. Giganti, G. Ciliberti, M. F. Foschino Barbaro
{"title":"特发性肺纤维化患者接受吡非尼酮或尼达尼布抗纤维化治疗后的肺动脉高压:临床评价和预后影响","authors":"S. R. Stornelli, D. Lacedonia, G. Scioscia, F. Simone, G. Lepore, R. Sabato, G. Giganti, G. Ciliberti, M. F. Foschino Barbaro","doi":"10.1183/13993003.congress-2021.pa3746","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":13242,"journal":{"name":"Idiopathic interstitial pneumonias","volume":"31 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT\",\"authors\":\"S. R. Stornelli, D. Lacedonia, G. Scioscia, F. Simone, G. Lepore, R. Sabato, G. Giganti, G. Ciliberti, M. F. Foschino Barbaro\",\"doi\":\"10.1183/13993003.congress-2021.pa3746\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":13242,\"journal\":{\"name\":\"Idiopathic interstitial pneumonias\",\"volume\":\"31 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Idiopathic interstitial pneumonias\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.congress-2021.pa3746\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Idiopathic interstitial pneumonias","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2021.pa3746","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT